Barclays Initiates Coverage On Cardinal Health with Overweight Rating, Announces Price Target of $117
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Stephanie Davis has initiated coverage on Cardinal Health (NYSE:CAH) with an Overweight rating and set a price target of $117.

January 03, 2024 | 10:23 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays has initiated coverage on Cardinal Health with an Overweight rating and a price target of $117, indicating a positive outlook for the stock.
Analyst ratings, especially from major financial institutions like Barclays, can significantly influence investor sentiment and stock prices. An Overweight rating suggests that Barclays believes Cardinal Health's stock will outperform the average return of the stocks in the analyst's coverage universe. The announcement of a price target of $117, which is presumably higher than the current trading price, indicates an expectation of upward movement in the stock's price, which could lead to increased investor interest and a potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100